Skip to content
Screener

Incyte INCY Other income, net (Note 6)

Other income, net (Note 6) at other companies

Pfizer logo
PfizerPFE
$3.72B+603%
Geron logo
GeronGERN
-$9K+85.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$81K-325%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$186K+15.8%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$119K-77.2%
AbbVie logo
AbbVieABBV
$1.48B+156%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24B+58.2%
Enterprise value$20.05B+51.3%
P/E14.9×-2.5×
P/S4.1×+0.8×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Incyte’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income38,11825,13671,80548,065
Interest expense(582)(594)(1,151)(1,254)
Gain (loss) on equity investments9,805(4,151)16,396(5,494)
Other, net6,2757,3079,04915,403
Income before provision for income taxes751,514558,0121,095,114792,202
Provision for income taxes165,909153,013206,179229,000
Net income$585,605$404,999$888,935$563,202
Net income per share:

Item 1. Financial Statements

FAQ

What is Incyte's other income, net (note 6)?
Incyte (INCY) reported other income, net (note 6) of $6.28M in Q2 2026.
How has Incyte's other income, net (note 6) changed year-over-year?
Incyte's other income, net (note 6) decreased by 14.1% year-over-year, from $7.31M to $6.28M.
What is the long-term trend for Incyte's other income, net (note 6)?
Over 3 years (2021 to 2025), Incyte's other income, net (note 6) has grown at a 33.1% compound annual growth rate (CAGR), from $10.65M to $25.11M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Incyte's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude